Abstract:Jian Sun, 1, &ast Zhaochun Tian, 2, &ast Jing Wu, 3 Jiafei Li, 3 Qixia Wang, 3 Shuhong Huang, 2, 3 Meng Wang 4 1 First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China; 2 Science and Technology Innovation Center, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China; 3 School of Clinical and Basic Medical Sciences, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, People's Republic of China; 4 Department of General Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Meng Wang, Department of general surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 16369, Jingshi Road, Jinan, Shandong, 250014, People's Republic of China, Email Shuhong Huang, School of Clinical and Basic Medical Sciences, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 6699, Qingdao Road, Jinan, Shandong, 250117, People's Republic of China, Email Pristimerin, a natural triterpenoid isolated from the plants of southern snake vine and Maidenwood in the family Weseraceae, is anti-inflammatory, insecticidal, antibacterial, and antiviral substance and has been used for its cardioprotective and antitumor effects and in osteoporosis treatment. These qualities explain Pristimerin's therapeutic effects on different types of tumors and other diseases. More and more studies have shown that pristimerin acts in a wide range of biological activities and has shown great potential in various fields of modern and Chinese medicine. While Pristimerin's wide range of pharmacological effects have been widely studied by others, our comprehensive review suggests that its mechanism of action may be through affecting fundamental cellular events, including blocking the cell cycle, inducing apoptosis and autophagy, and inhibiting cell migration and invasion, or through activating or inhibiting certain key molecules in several cell signaling pathways, including nuclear factor κB (NF-κB), phosphatidylinositol 3-kinase/protein kinase B/mammalian-targeted macromycin (PI3K/Akt/mTOR), mitogen-activated protein kinases (MAPKs), extracellular signal-regulated protein kinase 1/2 (ERK1/2), Jun amino-terminal kinase (JNK1/2/3), reactive oxygen species (ROS), wingless/integrin1 (Wnt)/β-catenin, and other signaling pathways. This paper reviews the research progress of Pristimerin's pharmacological mechanism of action in recent years to provide a theoretical basis for the molecular targeting therapy and further development and utilization of Pristimerin. It also provides insights into improved treatments and therapies for clinical patients and the need to explore pristimerin as a potential facet of treatment. Keywords: pristimerin, signaling pathway, pharmacological effects, review In recent years, natural compounds have attracted much attention in the treatment of human diseases due to their long history of use, diverse pharmacological effects and better safety than synthetic compounds.Pristimerin is a natural triterpenoid with orange-yellow needle-like crystals, a density of 1.16 g/cm3, a melting point of 214~217 °C, a boiling point of 607.7 °C, a refractive index of 1.582, a molecular weight of 464.64, and a molecular formula of C 30 H 40 O 4 . Pristimerin can be dissolved in methanol, ethanol, dimethylsulfoxide, and other organic solvents (Figure 1). 1 It is widely found in a variety of Weigeliaceae plants, such as southern snake vine (Celastrus orbiculatus Thunb.) and Maidenwood (Gymnosporia acuminata Hook. f.), and can be used in traditional Chinese medicine to treat a variety of diseases. There is considerable evidence that many natural products from traditional Chinese medicine, such as resveratrol, dioscin, berberine and curcumin, have antitumor effects.In contrast, Pristimerin has a broader range of biological effects, including anti-inflammatory, insecticidal, antibacterial, and antiviral effects and has been used for the treatment of osteoporosis and for cardioprotection, anti-tumor, and other biological effects.In addition, Pristimerin has significant potential for clinical application than other triterpenoids because it is a methyl ester of tretinoin, which not only acts similarly to tretinoin, but is also structurally stable, soluble, simple to obtain, has fewer toxic side effects, and inhibits tumor cell proliferation in a time- and dose-dependent manner. According to existi -Abstract Truncated-

Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3

Pristimerin Inhibits Breast Cancer Cell Migration by Up- Regulating Regulator of G Protein Signaling 4 Expression.

Pristimerin induces apoptosis and inhibits proliferation, migration in H1299 Lung Cancer Cells

Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation

Pristimerin Demonstrates Anticancer Potential in Colorectal Cancer Cells by Inducing G1 Phase Arrest and Apoptosis and Suppressing Various Pro-Survival Signaling Proteins

Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells

Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling

Pristimerin Effectively Inhibits the Malignant Phenotypes of Uveal Melanoma Cells by Targeting NF-κB Pathway

Pristimerin induces apoptosis and autophagy via activation of ROS/ASK1/JNK pathway in human breast cancer in vitro and in vivo

Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-кB signaling pathway in colorectal cancer cells

Pristimerin‐induced Uveal Melanoma Cell Death Via Inhibiting PI3K/Akt/FoxO3a Signalling Pathway

Pristimerin Induces Apoptosis In Imatinib-Resistant Chronic Myelogenous Leukemia Cells Harboring T315i Mutation By Blocking Nf-Kappa B Signaling And Depleting Bcr-Abl

Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells

Pristimerin Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review

Anticancer Potential and Molecular Targets of Pristimerin: A mini-review.

Matrine Inhibits Invasiveness and Metastasis of Human Malignant Melanoma Cell Line A375 in Vitro

Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling

Pristimerin Inhibits Thioredoxin Reductase in the Treatment of Non-Small Cell Lung Cancer

Pristimerin Inhibits Glioma Progression by Targeting AGO2 and PTPN1 Expression via miR-542-5p.

The N-terminal Polypeptide Derived from Viral Macrophage Inflammatory Protein II Reverses Breast Cancer Epithelial-to-mesenchymal Transition Via a PDGFRα-dependent Mechanism

The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art